Suppr超能文献

过氧化物酶体增殖剂:受体介导的致癌作用模型

Peroxisome proliferators: a model for receptor mediated carcinogenesis.

作者信息

Green S

机构信息

Imperial Chemical Industries, Central Toxicology Laboratory, Macclesfield, Cheshire.

出版信息

Cancer Surv. 1992;14:221-32.

PMID:1330305
Abstract

Peroxisome proliferators are a diverse group of rodent hepatocarcinogens, which include hypolipidaemic drugs, plasticizers and herbicides. A member of the nuclear hormone receptor superfamily has been identified that can be activated by peroxisome proliferators. The receptor is therefore termed the peroxisome proliferator activated receptor (PPAR). Three Xenopus nuclear hormone receptors have been described that are closely related to the mouse PPAR and can all be activated by peroxisome proliferators. Therefore, a family of PPARs that is possibly important in mediating the action of some hypolipidaemic drugs may exist in many species including mice and humans. The most widely used marker of peroxisome proliferator action is the peroxisomal beta-oxidation enzyme acyl CoA oxidase. PPAR recognizes a specific peroxisome proliferator response element located in the acyl CoA oxidase gene promoter. It is therefore argued that the hypolipidaemic and carcinogenic effects of peroxisome proliferators may be mediated by PPAR in a manner similar to that of steroid hormone action.

摘要

过氧化物酶体增殖剂是一类多样的啮齿动物肝癌致癌物,包括降血脂药物、增塑剂和除草剂。已鉴定出一种核激素受体超家族成员可被过氧化物酶体增殖剂激活。因此,该受体被称为过氧化物酶体增殖剂激活受体(PPAR)。已描述了三种非洲爪蟾核激素受体,它们与小鼠PPAR密切相关,且均可被过氧化物酶体增殖剂激活。因此,包括小鼠和人类在内的许多物种中可能存在一个PPAR家族,其在介导某些降血脂药物的作用方面可能很重要。过氧化物酶体增殖剂作用最广泛使用的标志物是过氧化物酶体β氧化酶酰基辅酶A氧化酶。PPAR识别位于酰基辅酶A氧化酶基因启动子中的特定过氧化物酶体增殖剂反应元件。因此有人认为,过氧化物酶体增殖剂的降血脂和致癌作用可能由PPAR以类似于类固醇激素作用的方式介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验